{"log_id": 7358371322885965626, "direction": 0, "words_result_num": 32, "words_result": [{"probability": {"variance": 0.000137, "average": 0.983622, "min": 0.971933}, "location": {"width": 19, "top": 188, "height": 20, "left": 190}, "words": "10"}, {"probability": {"variance": 2e-06, "average": 0.998753, "min": 0.992898}, "location": {"width": 818, "top": 167, "height": 43, "left": 270}, "words": "伴有头晕或包括视觉障碍在内的其他中枢神经系统障碍的病人,不应驾驶或操作机器"}, {"probability": {"variance": 0.001367, "average": 0.988828, "min": 0.776003}, "location": {"width": 905, "top": 223, "height": 36, "left": 190}, "words": "11、根据控制症状的需要,在最短治疗时间内使用最低有效剂量,可以使不良反应降到最低"}, {"probability": {"variance": 1.2e-05, "average": 0.997804, "min": 0.982233}, "location": {"width": 912, "top": 278, "height": 30, "left": 192}, "words": "2、在使用所有非甾体抗炎药治疗过程中的任何时候,都可能出现胃肠道出血、溃疡和穿孔"}, {"probability": {"variance": 5.7e-05, "average": 0.997646, "min": 0.960261}, "location": {"width": 883, "top": 326, "height": 33, "left": 224}, "words": "的不良反应,其风险可能是致命的。这些不良反应可能伴有或不伴有警示症状,也无论患者"}, {"probability": {"variance": 0.000212, "average": 0.99484, "min": 0.916142}, "location": {"width": 882, "top": 375, "height": 36, "left": 225}, "words": "是否有胃肠道不良反应史或严重的胃肠事件病史。既往有胃肠道病史(溃疡性大肠炎,克隆"}, {"probability": {"variance": 1.2e-05, "average": 0.997555, "min": 0.980876}, "location": {"width": 878, "top": 425, "height": 33, "left": 227}, "words": "氏病)的患者应谨慎使用非甾体抗炎药,以免使病情恶化。当患者服用该药发生胃肠道出血"}, {"probability": {"variance": 4.3e-05, "average": 0.997075, "min": 0.969941}, "location": {"width": 880, "top": 474, "height": 35, "left": 226}, "words": "或溃疡时,应停药。老年患者使用非甾体抗炎药出现不良反应的频率增加,尤其是胃肠道出"}, {"probability": {"variance": 2e-06, "average": 0.99876, "min": 0.994468}, "location": {"width": 305, "top": 525, "height": 28, "left": 226}, "words": "血和穿孔,其风险可能是致命的"}, {"probability": {"variance": 0.005278, "average": 0.978601, "min": 0.54355}, "location": {"width": 917, "top": 571, "height": 39, "left": 191}, "words": "1、针对多种COX-2选择性或非选择性 NSAIDS药物持续时间达3年的临床试验显示,本"}, {"probability": {"variance": 0.000302, "average": 0.996394, "min": 0.888115}, "location": {"width": 872, "top": 621, "height": 37, "left": 224}, "words": "品可能引起严重心血管血栓性不良事件、心肌梗塞和中风的风险增加,其风险可能是致命的"}, {"probability": {"variance": 0.003928, "average": 0.979219, "min": 0.661981}, "location": {"width": 881, "top": 670, "height": 38, "left": 224}, "words": "所有的 NSAIDS,包括COX-2选择性或非选择性药物,可能有相似的风险。有心血管疾病或"}, {"probability": {"variance": 1.6e-05, "average": 0.998196, "min": 0.975506}, "location": {"width": 880, "top": 719, "height": 38, "left": 224}, "words": "心血管疾病危险因素的患者,其风险更大。即使既往没有心血管症状,医生和患者也应对此"}, {"probability": {"variance": 0.002256, "average": 0.98732, "min": 0.713018}, "location": {"width": 880, "top": 768, "height": 39, "left": 223}, "words": "类事件的发生保持警惕。应告知患者严重心血管安全性的症状和/或体征以及如果发生应采取"}, {"probability": {"variance": 2.3e-05, "average": 0.996389, "min": 0.989612}, "location": {"width": 68, "top": 820, "height": 26, "left": 223}, "words": "的步骤"}, {"probability": {"variance": 9.1e-05, "average": 0.996298, "min": 0.940932}, "location": {"width": 882, "top": 865, "height": 41, "left": 221}, "words": "患者应该警惕诸如胸痛、气短、无力、言语含糊等症状和体征,而且当有任何上述症状或体"}, {"probability": {"variance": 4e-06, "average": 0.998065, "min": 0.993729}, "location": {"width": 305, "top": 917, "height": 27, "left": 222}, "words": "征发生后应该马上寻求医生帮助"}, {"probability": {"variance": 0.005657, "average": 0.984062, "min": 0.528997}, "location": {"width": 913, "top": 964, "height": 42, "left": 188}, "words": "14:和所有非甾体抗炎药( NSAIDS)一样,本品可导致新发高血压或使已有的高血压症状"}, {"probability": {"variance": 0.000109, "average": 0.995551, "min": 0.946776}, "location": {"width": 879, "top": 1011, "height": 44, "left": 219}, "words": "加重,其中的任何一种都可导致心血管事件的发生率增加。服用噻嗪类或髓袢利尿剂的患者"}, {"probability": {"variance": 0.000107, "average": 0.993923, "min": 0.954042}, "location": {"width": 879, "top": 1061, "height": 44, "left": 219}, "words": "服用非甾体抗炎药( NSAIDS)时,可能会影响这些药物的疗效。高血压病患者应慎用非甾体"}, {"probability": {"variance": 0, "average": 0.992671, "min": 0.992671}, "location": {"width": 21, "top": 1066, "height": 26, "left": 1201}, "words": "2"}, {"probability": {"variance": 0.000352, "average": 0.992107, "min": 0.918723}, "location": {"width": 786, "top": 1112, "height": 42, "left": 217}, "words": "抗炎药( NSAIDS),包括本品。在开始本品治疗和整个治疗过程中应密切监测血压"}, {"probability": {"variance": 0.000261, "average": 0.992531, "min": 0.925074}, "location": {"width": 695, "top": 1162, "height": 39, "left": 187}, "words": "15、有高血压和或心力衰竭(如液体潴留和水肿)病史的患者应慎用"}, {"probability": {"variance": 0.017116, "average": 0.866708, "min": 0.735879}, "location": {"width": 18, "top": 1216, "height": 20, "left": 190}, "words": "16"}, {"probability": {"variance": 0.037209, "average": 0.885986, "min": 0.365051}, "location": {"width": 795, "top": 1205, "height": 59, "left": 262}, "words": " NSAIDS,,包括本品可能引起致命的、严重的皮肤不良反摩性SC"}, {"probability": {"variance": 0.027719, "average": 0.908761, "min": 0.389446}, "location": {"width": 871, "top": 1257, "height": 54, "left": 223}, "words": " OHNSON综合征(SJS)和中毒性表皮坏死溶解症(T)这些严重事件可没有兆的"}, {"probability": {"variance": 0.010163, "average": 0.960182, "min": 0.526366}, "location": {"width": 876, "top": 1305, "height": 51, "left": 215}, "words": "情况下出现。应告知患者严重皮肤反应的症状和体征,在第二次出现皮肤皮疹或过敏皮应的"}, {"probability": {"variance": 1.2e-05, "average": 0.997604, "min": 0.988388}, "location": {"width": 241, "top": 1356, "height": 34, "left": 212}, "words": "其他征象时,应停用本品"}, {"probability": {"variance": 1e-06, "average": 0.99933, "min": 0.997239}, "location": {"width": 327, "top": 1408, "height": 33, "left": 260}, "words": "药品应保存在儿童不能触及的地方"}, {"probability": {"variance": 0.025674, "average": 0.948398, "min": 0.44171}, "location": {"width": 245, "top": 1506, "height": 32, "left": 180}, "words": "江孕妇及哺乳期妇女用药"}, {"probability": {"variance": 1e-06, "average": 0.999297, "min": 0.99666}, "location": {"width": 215, "top": 1552, "height": 34, "left": 213}, "words": "孕妇及哺乳期妇女禁用"}, {"probability": {"variance": 0.022262, "average": 0.924194, "min": 0.62579}, "location": {"width": 110, "top": 1601, "height": 24, "left": 174}, "words": "道儿童用药"}], "language": 3}